Page last updated: 2024-08-26

n-methyladenosine and Cancer of Prostate

n-methyladenosine has been researched along with Cancer of Prostate in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's11 (100.00)2.80

Authors

AuthorsStudies
Cai, C; Duan, X; Liang, Y; Lin, Z; Liu, Q; Liu, Z; Lu, J; Sun, X; Wu, W; Zeng, G; Zeng, J; Zhong, J; Zhong, W1
Feng, Y; Mi, Y; Wan, H; Wu, J; Zhu, L1
Han, M; Liu, J; Song, Y; Wang, C; Wang, Y; Yan, F1
Deng, Y; Lin, H; Liu, Y; Luo, L; Wang, J; Xiang, Q; Zhao, Z; Zhou, M; Zhu, Z1
Du, C; Feng, Y; Lv, C; Yu, S1
Chen, H; He, L; Li, J; Liang, Z; Liu, B; Wang, X; Xie, H; Xie, L; Xu, M; Xu, X; Yan, H; Ying, Y; Zheng, X1
Niu, Y; Wei, Y; Wen, S; Xiong, W; Zen, C; Zhao, Y1
Liu, JH; Ou-Yang, S; Wang, QZ1
Li, Y; Xu, Y; Zhu, K1
Dai, Y; Du, H; Lang, C; Li, Y; Lin, K; Peng, X; Ren, D; Wu, Z; Yang, Q; Yin, C1
Chen, P; Chen, Y; Han, X; Hu, J; Ma, Y; Pan, C; Rao, Q; Wang, X; Xiang, Z; Xu, D1

Reviews

1 review(s) available for n-methyladenosine and Cancer of Prostate

ArticleYear
Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review).
    Molecular medicine reports, 2022, Volume: 26, Issue:3

    Topics: Adenosine; Epigenesis, Genetic; Humans; Male; Prostatic Neoplasms

2022

Other Studies

10 other study(ies) available for n-methyladenosine and Cancer of Prostate

ArticleYear
Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Adenosine; Biomarkers, Tumor; Clinical Decision-Making; Databases, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Lymphocytes, Tumor-Infiltrating; Male; Methyltransferases; Nuclear Proteins; Prostatic Neoplasms; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; T-Lymphocytes, Helper-Inducer; Transcriptome; Tumor Microenvironment; Tumor-Associated Macrophages

2021
Cyclodextrin-Functionalized Gold Nanorods Loaded with Meclofenamic Acid for Improving
    ACS applied materials & interfaces, 2022, Sep-14, Volume: 14, Issue:36

    Topics: Adenosine; Cell Line, Tumor; Cyclodextrins; Gold; Humans; Immunotherapy; Male; Meclofenamic Acid; Nanotubes; Phototherapy; Prostatic Neoplasms; RNA; Tumor Microenvironment

2022
The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer.
    Future oncology (London, England), 2020, Volume: 16, Issue:30

    Topics: Adenosine; Cluster Analysis; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; RNA, Messenger; ROC Curve; Transcriptome

2020
Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
    Journal of experimental & clinical cancer research : CR, 2020, Oct-21, Volume: 39, Issue:1

    Topics: Adenosine; Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Microtubule-Associated Proteins; Prognosis; Prostatic Neoplasms; Retinoblastoma-Binding Protein 2; RNA-Binding Proteins; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2020
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Molecular cancer, 2020, 10-29, Volume: 19, Issue:1

    Topics: Adenosine; Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Prognosis; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; RNA Stability; RNA-Binding Proteins; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2020
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
    Molecular cancer, 2020, 12-12, Volume: 19, Issue:1

    Topics: Adenosine; Aged; Aged, 80 and over; Animals; Bone Neoplasms; Cell Line, Tumor; Core Binding Factor Alpha 1 Subunit; Cyclin-Dependent Kinases; Cyclins; Humans; Male; Mice, Nude; Middle Aged; Phosphorylation; Phosphoserine; Prognosis; Promoter Regions, Genetic; Prostatic Neoplasms; RNA Polymerase II; RNA, Long Noncoding

2020
Expression patterns and a prognostic model of m
    Biomarkers in medicine, 2020, Volume: 14, Issue:17

    Topics: Adenocarcinoma; Adenosine; Aged; Biomarkers, Tumor; Gene Expression Profiling; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Proteins; Prognosis; Prostatic Neoplasms; Risk Assessment

2020
The FTO m
    Life sciences, 2021, Apr-15, Volume: 271

    Topics: Adenosine; Aged; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Cell Movement; Humans; Male; Middle Aged; Neoplasm Invasiveness; Prostate; Prostatic Neoplasms

2021
m
    Clinical and translational medicine, 2021, Volume: 11, Issue:6

    Topics: Adenosine; Animals; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Cell Cycle; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prognosis; Prostatic Neoplasms; Receptor, IGF Type 1; RNA Stability; RNA-Binding Proteins; RNA, Long Noncoding; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021
Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
    Theranostics, 2021, Volume: 11, Issue:16

    Topics: Adenosine; Cell Movement; Cell Proliferation; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Methyltransferases; Neoplasm Invasiveness; Neoplasm Metastasis; Prostate; Prostatic Neoplasms; RNA-Binding Proteins; RNA, Messenger; Ubiquitin-Specific Proteases

2021